Knowledge Management System of Hefei Institute of Physical Science,CAS
The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma | |
Ding, Kaiyang1; Shi, Xiao2; Yang, Haiyan3; Cao, Lei2; Zhao, Xiaoli2; Liu, Hailing2; Wu, Wei2; Zhang, Xiaoyan2; Wang, Li2; Xu, Wei2; Zhu, Huayuan2; Li, Jianyong2,4; Fan, Lei2,4 | |
2021-11-23 | |
发表期刊 | BLOOD |
ISSN | 0006-4971 |
DOI | 10.1182/blood-2021-150523 |
收录类别 | SCI |
语种 | 英语 |
WOS研究方向 | Hematology |
WOS类目 | Hematology |
WOS记录号 | WOS:000736413901190 |
出版者 | AMER SOC HEMATOLOGY |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.hfcas.ac.cn:8080/handle/334002/131853 |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.USTC, Affiliated Hosp 1, Dept Hematol, Anhui Prov Hosp, Hefei, Peoples R China 2.Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China 4.Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Ding, Kaiyang,Shi, Xiao,Yang, Haiyan,et al. The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma[J]. BLOOD,2021,138. |
APA | Ding, Kaiyang.,Shi, Xiao.,Yang, Haiyan.,Cao, Lei.,Zhao, Xiaoli.,...&Fan, Lei.(2021).The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma.BLOOD,138. |
MLA | Ding, Kaiyang,et al."The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma".BLOOD 138(2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论